drugset / Trial / NCT00296725

Dichotic Listening as a Predictor of Medication Response in Depression

NCT00296725

Phase 1/2 Completed 25 enrolled New York State Psychiatric Institute
SequentialOpen-labelTreatment

Summary

Depressed patients will have hearing tests and then be treated with up to three treatments (i.e., Fluoxetine, Imipramine) until remitted, to see whether test results predict specific outcomes.

Timeline

Start
1994-04
Primary completion
2011-06
Completion
2011-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluoxetine Small molecule 80 mg
Subject Imipramine Small molecule 300 mg